NORTHERN TRUST CORP - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 21 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,085
+2.3%
36,814
+41.6%
0.00%
Q2 2023$21,580
+135.4%
25,9930.0%0.00%
Q1 2023$9,168
-17.5%
25,9930.0%0.00%
Q4 2022$11,114
-25.9%
25,9930.0%0.00%
Q3 2022$15,000
-59.5%
25,9930.0%0.00%
Q2 2022$37,000
-44.8%
25,993
+55.2%
0.00%
Q1 2022$67,000
-51.4%
16,745
+0.5%
0.00%
Q4 2021$138,00016,6570.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders